Alzheimer's Disease Market Research Reports & Industry Analysis
A gradual loss of neurons later in adulthood does not result in significant alteration in brain function during the usual life span. However, the older one gets, the greater the neurologic impairment. Excessive neuronal degeneration in adulthood is called Alzheimer’s disease or senile dementia and is distinguished from the normal changes in aging. Alzheimer’s disease is a progressive disease which results in death of the brain cells causing memory lapses, behavioral issues, and disruption of thinking processes. The disease is considered fatal. Age and generic inheritance are the two key risk factors for developing Alzheimer’s disease. These are also risk factors that are not preventable. However, other preventable risk factors have been linked to the development of AD, including environment, diet, and overall general health. A combination of risk factors is often responsible for the disease.
Alzheimer’s disease is estimated to affect up to 6% of the population over 65. Life expectancy has been increasing around the world due to advances in healthcare, medical research, sanitation, and nutrition. This provides a setting for a higher number of Alzheimer’s disease patients in the future as the population continues to add years to their life.
Alzheimer's Disease Industry Research & Market Reports
-
Neuroprosthetics Market Size, Trends, Analysis, and Outlook By Type (Output Neural Prosthetics, Input Neural Prosthetics), By Technique (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Others), By Application (Parkinson's Disease, Alzheimer's Disease, Epilepsy, Auditory Processing Disorders, Ophthalmic Disorders, Others), by Country, Segment, and Companies, 2024-2032
... Processing Disorders, Ophthalmic Disorders, Others), by Country, Segment, and Companies, 2024-2032 The global Neuroprosthetics market size is poised to register 11.7% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the ... Read More
-
Neuroprotective Agents Market Size, Trends, Analysis, and Outlook By Drug Class (Anesthetics, Antagonists, Antidepressants, Cytokines, Others), By Application (Alzheimer's disease, Dementia, Epilepsy, Multiple sclerosis, Others), By Route of Administration (Oral, Topical, Epidural, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), by Country, Segment, and Companies, 2024-2032 The global Neuroprotective Agents market size is poised to register 7.2% growth from 2024 to 2032, presenting significant growth prospects for companies ... Read More
-
Neurological Disorder Drugs Market Size, Trends, Analysis, and Outlook By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032 The global Neurological Disorder Drugs market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size, Trends, Analysis, and Outlook By Therapeutics (Marketed Drugs, Pipeline Drugs), By Diagnostics (Lumbar Puncture Test, Computed Tomography Scan, Magnetic Resonance Imaging, Electroencephalography, Positron Emission Tomography Scan, Others), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Alzheimer's Disease Diagnostics and Therapeutics market size is poised to register 5.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Neurodegenerative Disease Market Size, Trends, Analysis, and Outlook By Indication (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Others), By Drug (N-methyl-D-aspartate Receptor Antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Others), by Country, Segment, and Companies, 2024-2032
... Companies, 2024-2032 The global Neurodegenerative Disease market size is poised to register 7.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neurodegenerative ... Read More
-
2024 Global Forecast for Alzheimer'S Disease Drug Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Predictive Presymptomatic Testing Market Size, Trends, Analysis, and Outlook By Condition (Breast and Ovarian Cancer , Colorectal Cancer , Alzheimer's Disease , Multiple Endocrine Neoplasia Type 2 , Haemochromatosis), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Predictive Presymptomatic Testing market size is poised to register 9.88% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Melatonin Supplements Market Size, Trends, Analysis, and Outlook By Type (Tablet, Capsule), By Application (Alzheimer's Disease, Weak immune System, Osteoporosis, Cancer Treatment, Nerve Pain, Others), By Distribution Channel (Supermarkets and Hypermarkets, Departmental Stores, Specialty Shops, E Commerce Platforms), By End-User (Pharmaceuticals, Food and Beverage, Medical and Healthcare, Others), by Region, Country, Segment, and Companies, 2024-2030
... E Commerce Platforms), By End-User (Pharmaceuticals, Food and Beverage, Medical and Healthcare, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Melatonin Supplements market size is poised to register 12.8% growth (CAGR) from 2024 ... Read More
-
Gene Therapy for CNS Disorders Market Size, Trends, Analysis, and Outlook By Indication (Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Batten Disease), By Type (Ex Vivo, In Vivo), By End-User (Hospitals, Speciality Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Gene Therapy for CNS Disorders market size is poised to register 25.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Mental Health Screening Market by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting - Global Forecast to 2029
... projected to reach USD 1.8 billion by 2029 from USD 0.9 billion in 2023, at a CAGR 12.2% during the forecast period. The rising awareness of mental health issues due to the growing geriatric population ... Read More
-
Oral Clinical Nutrition Market Size, Trends, Analysis, and Outlook By Stage (Adults, Pediatrics), By Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others), By Sales Channel (Online Sales, Retail Sales, Institutional Sales), by Region, Country, Segment, and Companies, 2024-2030
... (Online Sales, Retail Sales, Institutional Sales), by Region, Country, Segment, and Companies, 2024-2030 The global Oral Clinical Nutrition market size is poised to register 6.09% growth from 2024 to 2030, presenting significant growth prospects for ... Read More
-
Brain Implants Market Size, Trends, Analysis, and Outlook By Product (Deep Brain Stimulator, Spinal Cord Stimulator, Vagus Nerve Stimulator), By Application (Chronic pain, Epilepsy, Parkinson's, Depression, Essential Tremor, Alzheimer's), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Brain Implants market size is poised to register 10.1% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Brain Implants ... Read More
-
Neurological Biomarkers Market Size, Trends, Analysis, and Outlook By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others), by Region, Country, Segment, and Companies, 2024-2030
... diagnostic centers, Research Organizations, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Neurological Biomarkers market size is poised to register 14.63% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Drug Delivery Across Blood-Brain Barrier Market Size, Trends, Analysis, and Outlook By Drug Delivery Technology (Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion, Others), By Application (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others), by Region, Country, Segment, and Companies, 2024-2030
... Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Drug Delivery Across Blood-Brain Barrier market size is poised to register 19.61% growth from 2024 to 2030, ... Read More
-
Active Wheelchair Market Size, Trends, Analysis, and Outlook By Product (Manual Wheelchairs, Power Wheelchairs), By Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury, Others), by Region, Country, Segment, and Companies, 2024-2030
... Cord Injury, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Active Wheelchair market size is poised to register 5.04% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Trends, Analysis, and Outlook By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics Application, Research Application), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Immunoassay for Neurological Biomarkers market size is poised to register 17.33% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
The 2025-2030 World Outlook for Drugs for Alzheimer's and Parkinson's Diseases
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Disorders
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Alzheimer's Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Dementia Associated with Alzheimer's Diseases
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Alzheimer's Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Neurological Biomarkers for Alzheimers and Parkinsons Diseases
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Alzheimer's Disease Therapeutics and Diagnostics
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Alzheimer's Disease Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
